PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.07 and traded as high as $0.08. PURE Bioscience shares last traded at $0.08, with a volume of 15,969 shares traded.
PURE Bioscience Stock Performance
The company has a 50 day moving average of $0.07 and a two-hundred day moving average of $0.07. The stock has a market capitalization of $9.09 million, a PE ratio of -2.33 and a beta of 0.27.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings results on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.51 million during the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
See Also
- Five stocks we like better than PURE Bioscience
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
